Early Access — free while we kick the tires
EdgarHawk

Malcolm Gregory

EVP and Controller

Officer
2 filings analyzed · 1 company · Latest 2026-02-10

Companies

Company Buys Sells Direction
COLGATE PALMOLIVE CO CL 0 4 Net selling

Activity

February 2026
medium
Sell
12,747 shares
$1,209,822
Significance 5/10

EVP Malcolm Gregory sold 12,747 shares of CL at $94.91 on 2026-02-06, reducing holdings by 51.8% to 11,879 shares; stock up 15.3% in 30d, 19.6% in 90d.

Malcolm Gregory sold 12,747 shares (12.7K shares) at $94.91 on 2026-02-06, a material 51.8% reduction in his position from 24,626 shares to 11,879 shares. His cross-ticker track record shows a 25.00% well-timed rate on prior sells with an average 90-day return of +2.3%, indicating modest accuracy in sell timing historically. At CL specifically, his 4 prior sells were well-timed in 1 of 4 instances at the 90-day mark. The stock has appreciated significantly since the sale (15.3% in 30 days, 19.6% in 90 days), now trading at $93.93 compared to the sale price of $94.91, within 3.7% of its 52-week high of $97.50. The company fundamentals remain solid with $75.7B market cap, a P/E of 26.02, and recent quarterly revenue of $5.1B with net income of $735.0M. This large, half-position sale by a senior controller occurred amid strong recent price momentum and merits monitoring to determine whether it signals operational changes or reflects routine portfolio management at CL.

August 2024
medium
Sell
10,533 shares
$1,085,957
Significance 5/10

EVP Malcolm Gregory sold 10,533 CL shares at $103.10, reducing holdings by 50.4% to 10,377 shares ($1.1M total).

Malcolm Gregory, EVP and Controller of Colgate-Palmolive, executed a substantial open-market sale of 10,533 shares at $103.10 on 2024-08-06, totaling $1,085,956.51, which reduced his holdings by 50.4% from 20,910 to 10,377 shares. At the transaction price of $103.10, the sale occurred very near the 52-week high of $102.81 (-0.1% from peak). His prior three sales at CL showed mixed post-transaction performance: the 2024-02-01 sale saw positive returns at both 30-day (+1.3%) and 90-day (+7.7%) intervals, while the two 2023 sales (August 30-31) both declined in the first 30 days (-3.7% and -3.8%) before recovering by 90 days (+5.4% each). None of his three prior CL sales were well-timed at the 90-day mark, meaning the stock rose after each sale. This transaction represents the largest single reduction in his CL position on record and coincides with CL trading at near all-time highs after a 5.8% 30-day advance and 8.0% 90-day gain, though the fundamental backdrop remains stable with recent quarterly revenue of $5,058,000,000 and net income of $731,000,000.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access